@article{9cc4de52490f46d184bf336fa1c0dd7b,
title = "In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d",
author = "Spyropoulos, \{A. C.\} and M. Goldin and D. Giannis",
note = "Funding Information: Funding: Department of National Defense, Canada; St. Michael's Hospital Foundation; St. Joseph's Health Centre Foundation; 2020 TD Community Health Solutions Fund; Michael Garron Hospital; The Ottawa Hospital Foundation COVID-19 Emergency Response Fund; International Network of Venous Thromboembolism Clinical Research Networks (INVENT) Kickstarter Award; Science Foundation Ireland; South-eastern Ontario Academic Medical Organization COVID-19 Innovation Fund; National Institutes of Health; University of Vermont Medical Center Fund Grant; King Saud University, Saudi Arabia.",
year = "2022",
month = feb,
day = "1",
doi = "10.7326/J21-0019",
language = "English",
volume = "175",
pages = "JC17",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",
}